Expertise in
6
conditions

Heinrich Resch

Vienna, AT 
Expertise in
6
conditions
Vienna, AT 

Overview

Heinrich Resch practices practicing medicine in Vienna, Austria.

Mr. Resch is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Hypophosphatasia (HPP), and Osteogenesis Imperfecta.

He is actively involved in clinical research, co-authoring 72 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Vienna, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

MicroRNAs Levels in Women With Postmenopausal Osteoporosis Under Antiresorptive or Osteoanabolic Treatment
MicroRNAs Levels in Women With Postmenopausal Osteoporosis Under Antiresorptive or Osteoanabolic Treatment
Enrollment Status: Completed
Publish Date: January 26, 2023
Intervention Type: Drug
Study Drugs: Denosumab, Teriparatide
Study Phase: Phase 4
Circulating miRNAs and Bone Microstructure in Adults With Hypophosphatasia
Circulating miRNAs and Bone Microstructure in Adults With Hypophosphatasia
Enrollment Status: Unknown
Publish Date: January 26, 2023
Intervention Type: Other
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 13, 2022
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

72 Total Publications

Prevalence of clinical manifestations among patients with hypophosphatasia in Central and Eastern European countries.
Prevalence of clinical manifestations among patients with hypophosphatasia in Central and Eastern European countries.
Journal: Frontiers in endocrinology
Published: May 27, 2026

Frequently Asked Questions about Heinrich Resch

Is Heinrich Resch a top-rated expert for Postmenopausal Osteoporosis?

MediFind is an objective health platform that identifies experts based on real-world data. Heinrich Resch is classified as an Elite expert for Postmenopausal Osteoporosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Heinrich Resch participate in research or clinical trials?

Yes. Heinrich Resch has published 72 articles and abstracts on conditions like Postmenopausal Osteoporosis. You can view a list of Heinrich Resch's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Resch's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile